What If Ketamine Tablet Stops Working?

It's a moment many patients on long-term ketamine tablet therapy face: the treatment that once reliably lifted depression or quieted pain starts to feel less effective. Doses that previously produced meaningful relief now seem to do less. Understanding why this happens and what options exist is critical to navigating this phase of treatment.

The Phenomenon: Tachyphylaxis vs. Tolerance vs. Relapse

Several distinct phenomena can masquerade as "ketamine stopping working," and distinguishing them changes the appropriate response:

Tachyphylaxis

Tachyphylaxis refers to a rapidly developing tolerance to a drug's effects — a decrease in response with repeated exposure. For ketamine, this can manifest as:

• The antidepressant effect becoming less pronounced with each session, even without changing the dose
• Requiring progressively higher doses to achieve the same effect (see titration protocols for how prescribers approach dose adjustments)
• A shortening of the duration between doses before the effect "wears off"

True tachyphylaxis to ketamine's antidepressant effects has been documented but appears to be less common than initially feared. Studies of long-term ketamine use suggest most patients maintain response at stable doses for 6–12+ months without true tachyphylaxis.

Pharmacological Tolerance

Classic pharmacological tolerance involves receptor-level changes (downregulation, desensitization) that reduce drug effect. For ketamine:

• NMDA receptor upregulation in response to chronic blockade could theoretically reduce efficacy
• This mechanism has been demonstrated in laboratory settings but its clinical significance at therapeutic dosing frequencies is debated
• Most clinical evidence suggests this is not a dominant concern at typical ketamine tablet dosing frequencies

Treatment Failure vs. Relapse

Not all cases of "ketamine stopping working" are pharmacological. Sometimes the issue is:

• Worsening underlying condition: Depression naturally fluctuates; a worsening episode may overwhelm even effective maintenance therapy
• Life circumstances: New stressors, relationship changes, bereavement, or other external factors can drive depression beyond what medication alone can address
• Accumulated medical factors: New illness, medication additions, hormonal changes, or other medical developments may be worsening depression independently of ketamine

Carefully examining what has changed since ketamine seemed to stop working often identifies contributing factors.

Step 1: Assess What Actually Changed

Before modifying your ketamine protocol, investigate:

Has anything changed in your life or health?

• New major stressor? Life event?
• New medical diagnosis?
• Recent illness, injury, or surgery?
• Changes in sleep (even small changes in sleep quality can significantly impact mood)

Has anything changed in your medication regimen?

• New medications added by any provider?
• Any over-the-counter additions (including supplements)?
• CYP3A4 inducers that might be reducing ketamine's effective exposure?

Has your dosing changed?

• Are you taking doses on a less consistent schedule?
• Has your fasting protocol changed?
• Have you been taking doses with food when you previously fasted?

Has your life support changed?

• Are you attending therapy less frequently?
• Have you reduced exercise, social activity, or other protective behaviors?
• Are you using alcohol or cannabis more frequently around dosing?

Step 2: Verify Therapeutic Exposure

It's worth confirming that you're actually getting adequate ketamine exposure:

Compounding pharmacy quality: Ask your pharmacy if they have recently changed their formulation, base, or API source. Pharmacy-level changes can affect drug content.

Storage and handling: Review whether your medication storage has been optimal. Temperature extremes or humidity can degrade ketamine tablet.

Formulation absorption: Are you still following the same protocol? If you switched from fasting to eating before doses, your bioavailability may have dropped.

Consider requesting a pharmacy potency test: If you're concerned about your medication's quality, ask your pharmacy whether they can test the potency of your current batch.

Step 3: Strategies to Restore Response

If investigation hasn't identified a clear external cause, several strategies may restore ketamine's effectiveness:

Drug Holiday

A structured temporary discontinuation — sometimes called a "ketamine holiday" — allows NMDA receptors to return to baseline, potentially restoring sensitivity to ketamine's effects when treatment is restarted.

Typical protocol:

• Duration: 1–4 weeks off ketamine
• Done under prescriber guidance with monitoring for mood deterioration
• Restart at a lower dose and retitrate
• Not appropriate for patients with high relapse risk during the break

Drug holidays have been used anecdotally with some success in patients with suspected tachyphylaxis, though controlled evidence for this approach is limited.

Dose Adjustment

Sometimes the appropriate response to reduced effectiveness is modest dose escalation:

• Increase dose by 10–25% and assess response over 2–4 weeks
• May increase dosing frequency (e.g., from twice weekly to three times weekly)
• Note: Escalating doses indefinitely is not sustainable and bladder safety requires attention at higher cumulative doses

Formulation Change

Switching from swallowed tablets to troches (with buccal/sublingual absorption) increases bioavailability by 10–20%. If you've been using tablets and response has waned, troches may restore effective plasma levels.

Route Change: Back to IV

If ketamine tablet has been working and then stops, returning to a brief course of IV ketamine (the "induction" phase) can often re-establish the neuroplastic response that oral maintenance then sustains. Many clinical programs use an "IV re-induction" model for patients whose oral maintenance response has faded.

Typical IV re-induction: 3–6 IV infusions over 2–3 weeks, followed by return to oral maintenance.

Augmentation Changes

Adding or adjusting concurrent antidepressant therapy may restore ketamine's effectiveness by addressing treatment factors that are no longer being adequately addressed:

• Adding lithium as augmentation (for its GSK-3β interaction with ketamine)
• Optimizing SSRI or SNRI dose
• Adding or adjusting an atypical antipsychotic augmentation agent

Intensive Psychotherapy

For some patients, the psychological and behavioral components of depression have not kept pace with ketamine's biological effects. Intensifying psychotherapy during this period — particularly ketamine-assisted psychotherapy or trauma-focused therapy — may re-establish the synergy between pharmacological and psychological treatment.

When to Consider Alternatives

If multiple strategies don't restore response, it may be time to consider:

Spravato (esketamine): The different enantiomeric composition and intranasal route may restore response in patients who have partially tachyphylaxed to racemic ketamine tablet.

IV ketamine clinic: A more robust ketamine course (multiple IV infusions) may achieve what oral cannot at this stage.

Other novel treatments: Psilocybin-assisted therapy, MDMA-assisted therapy (where available in clinical trials), TMS, ECT, or other evidence-based interventions for TRD.

Comprehensive medication reassessment: A fresh look at the entire antidepressant regimen with a psychopharmacology specialist may identify untried options.

What Not to Do

• Do not dramatically escalate your dose without prescriber guidance: Self-managed dose escalation risks bladder toxicity, cardiovascular effects, and psychological adverse events
• Do not abruptly stop ketamine: Gradual tapering is preferable to prevent discontinuation effects
• Do not give up immediately: Reduced response often responds to one of the strategies above; this phase of treatment is manageable with appropriate clinical support

The experience of ketamine "stopping working" is distressing but common and often reversible with appropriate clinical attention. The key is to communicate with your prescriber early, investigate systematically, and approach adjustments methodically.

References

• StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
• PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
• MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
• NIMH: Depression — National Institute of Mental Health overview of depressive disorders, treatment-resistant forms, and emerging therapies
• WHO: Depression Fact Sheet — World Health Organization global data on depression prevalence, burden, and treatment approaches